Understanding how genetic mutations in UBQLN2 lead to neurodegeneration in dementia
Genetic analysis of UBQLN2-associated neurodegeneration in frontotemporal dementia
This study is looking at how changes in a gene called UBQLN2 might lead to brain problems in people with frontotemporal dementia and ALS, using fruit flies and human cells to find out more about these changes and how they could help develop new treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10875745 on NIH RePORTER |
What this research studies
This research investigates the role of the UBQLN2 gene in causing neurodegeneration associated with frontotemporal dementia and amyotrophic lateral sclerosis. Using advanced models derived from fruit flies and human stem cells, the study aims to uncover how specific mutations in UBQLN2 contribute to the disease process. By examining the effects of these mutations on neuronal function and health, the research seeks to identify potential therapeutic targets for treatment. Patients may gain insights into the genetic factors influencing their condition and potential future therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with frontotemporal dementia or amyotrophic lateral sclerosis, particularly those with known UBQLN2 mutations.
Not a fit: Patients with neurodegenerative diseases not associated with UBQLN2 mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments or interventions for patients suffering from frontotemporal dementia and related neurodegenerative diseases.
How similar studies have performed: Previous research has shown promising results in understanding genetic contributions to neurodegeneration, suggesting that this approach could yield valuable insights.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Tibbetts, Randal Scot — University of Wisconsin-Madison
- Study coordinator: Tibbetts, Randal Scot
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.